Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Chest

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/CHEST.06-1500PMID 17218551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function tests.

  2009cited by this paper
• Pathophysiology of exacerbations of chronic obstructive pulmonary disease.

  2006cited by this paper
• Antibiotics for exacerbations of chronic obstructive pulmonary disease.

  2006cited by this paper
• Quality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2006cited by this paper
• COPD exacerbations · 1: Epidemiology

  2006cited by this paper
• Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection.

  2006cited by this paper
• Global burden of COPD: systematic review and meta-analysis

  2006cited by this paper
• Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

  2006cited by this paper
• Procalcitonin in bacterial infections--hype, hope, more or less?

  2005cited by this paper
• Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis.

  2005cited by this paper
• Burden and clinical features of chronic obstructive pulmonary disease (COPD).

  2004cited by this paper
• Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

  2004cited by this paper
• Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes*

  2004cited by this paper
• Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

  2004cited by this paper
• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

  2004cited by this paper
• New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

  2002cited by this paper
• Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.

  2001cited by this paper
• Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease

  2001cited by this paper
• Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis.

  2001cited by this paper
• Lipid Peroxidation and Changes of Glutathione Peroxidase Activity in Treatment of Chronic Obstructive Pulmonary Disease Exacerbation: Prognostic Value of Malondialdehyde

  2001cited by this paper
• Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.

  2001cited by this paper
• Management of acute exacerbations of COPD: a summary and appraisal of published evidence.

  2001cited by this paper
• Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

  2001cited by this paper
• The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee.

  2001cited by this paper
• The economic burden of COPD.

  2000cited by this paper
• Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

  2000cited by this paper
• Toward a consensus definition for COPD exacerbations.

  2000cited by this paper
• Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

  2000cited by this paper
• Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

  2000cited by this paper
• N-Acetylcysteine Reduces the Exacerbation Rate in Patients with Moderate to Severe COPD

  1999cited by this paper
• Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).

  1999cited by this paper
• Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.

  1998cited by this paper
• Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

  1998cited by this paper
• Guidelines for the treatment of acute exacerbations of chronic bronchitis.

  1997cited by this paper
• Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.

  1997cited by this paper
• Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.

  1996cited by this paper
• Systemic oxidative stress in asthma, COPD, and smokers.

  1996cited by this paper
• Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

  1996cited by this paper
• Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.

  1995cited by this paper
• Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.

  1995cited by this paper
• Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

  1995cited by this paper
• Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice.

  1992cited by this paper
• Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients.

  1990cited by this paper
• Predictive value of Glasgow coma score for awakening after out-of-hospital cardiac arrest. Cerebral Resuscitation Study Group of the Belgian Society for Intensive Care.

  1988cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline.

  1982cited by this paper
• Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis.

  1972cited by this paper
• Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.

  1968cited by this paper
• Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis.

  1965cited by this paper
• Antibiotic regimes in chronic bronchitis.

  1962cited by this paper
• Exacerbations of chronic bronchitis treatment with oxytetracycline.

  1960cited by this paper
• Prophylactic Use of Oxytetracycline for Exacerbations of Chronic Bronchitis

  1957cited by this paper

• Tratamiento de las infecciones respiratorias de vías bajas de la EPOC

  2025cites this paper
• Diagnostic value of procalcitonin for identifying the etiology of lower respiratory tract infections: a systematic review and meta-analysis

  2025cites this paper
• Role of soluble triggering receptor expressed on myeloid cells-1 and serum procalcitonin in exacerbation of chronic obstructive pulmonary disease

  2025cites this paper
• Procalcitonin in the management of lower respiratory tract infection and sepsis.

  2025cites this paper
• Phenotypes of Exacerbations in Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Management of COPD exacerbations in hospital emergency departments

  2025cites this paper
• Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials

  2024cites this paper
• Procalcitonin and qSOFA as a Marker of Mortality in Sepsis.

  2024cites this paper
• Diagnostic yield of viral multiplex PCR during acute exacerbation of COPD admitted to the intensive care unit: a pilot study

  2024cites this paper
• Role of biomarkers in antimicrobial stewardship: physicians’ perspectives

  2024cites this paper
• Inflammatory biomarker-based clinical practice in patients with pneumonia: A systematic review of randomized controlled trials

  2024cites this paper
• Procalcitonin Guided Antibiotic Stewardship

  2024cites this paper
• Integrative Molecular Structure Elucidation and Construction of an Extended Metabolic Pathway Associated with an Ancient Innate Immune Response in COVID-19 Patients

  2024cites this paper
• Association of antibiotics with the outcomes in COVID-19 pneumonia patients with elevated PCT levels.

  2024cites this paper
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for Antimicrobial Stewardship in Emergency Departments (endorsed by European Association of Hospital Pharmacists).

  2024cites this paper
• Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method

  2023cites this paper
• Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review

  2023cites this paper
• SARS-CoV-2 Infection Biomarkers Reveal an Extended RSAD2 Dependant Metabolic Pathway

  2023cites this paper
• Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022

  2023cites this paper
• Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review

  2023cites this paper
• Utility of Procalcitonin in Clinical Practice

  2023cites this paper
• Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use

  2023cites this paper
• Procalcitonin levels in pregnancy: A systematic review and meta‐analysis of observational studies

  2023cites this paper
• Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.

  2023cites this paper
• AACC Guidance Document on the Clinical Use of Procalcitonin.

  2023cites this paper
• Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival—a systematic review and meta-analysis

  2023cites this paper
• Measurement of Procalcitonin as an Indicator of Severity in Patients With Chronic Obstructive Pulmonary Disease Admitted With Respiratory Illness

  2022cites this paper
• Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.

  2022cites this paper
• Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study

  2022cites this paper
• Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19

  2022cites this paper
• Perfil de pacientes hospitalizados com doença pulmonar obstrutiva crônica

  2022cites this paper
• Inflammation in COVID-19: A Risk for Superinfections

  2022cites this paper
• Comparing Serum Procalcitonin Levels Between Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Patients with Acute Exacerbation of Asthma

  2022cites this paper
• The role of procalcitonin as a biomarker for acute pulmonary exacerbation in subjects with cystic fibrosis and non-cystic fibrosis bronchiectasis

  2022cites this paper
• Tratamiento de la exacerbación de la enfermedad pulmonar obstructiva crónica

  2022cites this paper
• Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.

  2022cites this paper
• Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection

  2022cites this paper
• The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review

  2022cites this paper
• SERUM PROCALCITONIN LEVEL IN ASSESSING THE SEVERITY AND DURATION OF HOSPITALIZATION IN PATIENTS WITH EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2022cites this paper
• Exploring the role of antibiotics and steroids in managing respiratory diseases

  2022cites this paper
• Prise en charge de l’exacerbation de la bronchopneumopathie chronique obstructive

  2022cites this paper
• Antibiotics Use among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study

  2022cites this paper
• Serial evaluation of thoracic radiographs and acute phase proteins in dogs with pneumonia

  2022cites this paper
• Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study

  2022cites this paper
• The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice – a study protocol

  2022cites this paper
• Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC

  2022cites this paper
• Gestione dell’esacerbazione della broncopneumopatia cronica ostruttiva

  2022cites this paper
• Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill

  2022cites this paper
• Procalcitonin-Guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations (PRECISION): Study Protocol for a Prospective Randomized Controlled Trial.

  2022cites this paper
• Recent Advances in Bedside Device-Based Early Detection of Sepsis

  2021cites this paper
• A retrospective analysis of the impact of a hospital pharmacist-led procalcitonin protocol.

  2021cites this paper
• Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study

  2021cites this paper
• Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial

  2021cites this paper
• CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia

  2021cites this paper
• Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin

  2021cites this paper
• Biomarkers in COPD

  2021cites this paper
• Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial

  2021cites this paper
• Diagnostic Accuracy and Prognostic Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Septic Patients outside the Intensive Care Unit

  2021cites this paper
• 2021 Guideline for the Management of COPD Exacerbations: Emergency Medicine Association of Turkey (EMAT) / Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force

  2021cites this paper
• The different phenotypes of COPD.

  2021cites this paper
• Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU

  2021cites this paper
• Effects Of Age, Body Mass Index, Complete Blood Count Parameters, and Biochemical Parameters on Stable COPD Patients

  2021cites this paper
• OP-JACR210153 1..3

  2021cites this paper
• Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations.

  2021cites this paper
• Interrelationships Between Serum Levels of Procalcitonin and Inflammatory Markers in Patients Who Visited a General Medicine Department.

  2021cites this paper
• Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics.

  2020cites this paper
• Procalcitonin Uptake and Effect on Antibiotics Stewardship: A Single Institution Experience

  2020cites this paper
• Biomarkers in intensive care: C-reactive protein and procalcitonin

  2020cites this paper
• A pregnancy-specific reference interval for procalcitonin.

  2020cites this paper
• Antibiotikatherapie im klinischen Alltag

  2020cites this paper
• Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Cipro fl oxacin A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial : Targeted Retreatment of Incompletely Recovered COPD Exacerbations with Ciprofloxacin

  2020cites this paper
• Biomarkers in Sepsis: A study of Procalcitonin as a diagnostic and prognostication tool in Sepsis in a tertiary care hospital

  2020cites this paper
• COPD_A_236305 567..574

  2020cites this paper
• Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU

  2020cites this paper
• Procalcitonin-Guided Antibiotic Discontinuation: An Antimicrobial Stewardship Initiative to Assist Providers

  2020cites this paper
• Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations

  2020cites this paper
• Procalcitonin Identifies Bacterial Coinfections in Vietnamese Children with Severe Respiratory Syncytial Virus Pneumonia

  2020cites this paper
• Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective

  2020cites this paper
• Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease

  2020cites this paper
• Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?

  2020cites this paper
• Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.

  2020cites this paper
• A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?

  2020cites this paper
• Targeted Retreatment of Incompletely Recovered COPD Exacerbations With Ciprofloxacin: A Double-blind, Randomised, Placebo-controlled, Multicentre Phase III Trial.

  2020cites this paper
• Acute exacerbation of chronic obstructive pulmonary disease in older people

  2019cites this paper
• The Effects Of De-Escalation Under the Guidance of Procalcitonin in Sepsis

  2019cites this paper
• Chronic Obstructive Pulmonary Disease Exacerbations: Current Controversies

  2019cites this paper
• PCT

  2019cites this paper
• Stellenwert des Procalcitonins als Sepsismarker

  2019cites this paper
• Differences of viral panel positive versus negative by real-time PCR in COPD exacerbated patients.

  2019cites this paper
• The Case of Procalcitonin for Lower Respiratory Tract Infections

  2019cites this paper
• Predictive factors for COPD exacerbations and mortality in patients with overlap syndrome

  2019cites this paper
• [Place of biomarkers in the management of pulmonary infections].

  2019cites this paper
• Seric Markers and Cell Profile in Blood and Sputum in Chronic Obstructive Pulmonary Disease Exacerbations (AECOPD)

  2019cites this paper
• Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?

  2019cites this paper
• Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

  2019cites this paper
• Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis

  2019cites this paper
• Procalcitonin and antibiotics in moderate–severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use

  2019cites this paper
• Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

  2019cites this paper
• Testovi opterećenja kronične opstruktivne bolesti pluća u stabilnom stanju i u egzacerbacijama

  2019cites this paper